Want to know how Netflix succeeds to be the premium player of the OTT Platform Industry and how does Netflix makes money through various business models and streaming partnerships. Do you know that ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time ...

In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most ...

Could Palantir Technologies stock (NASDAQ: PLTR) drop to $60 in the near future from its current price above $120? Does this ...

Money may speak, but do logos not whisper, scream or even sing? In this crowded global market for trust, the most precious currency of all, these small design heroes bear the brunt of their work. Have ...

With the Super Bowl officially wrapped up, and the Eagles taking the mantle away from the Chiefs in an epic showdown (beat ...

The iPhone 16e is officially here. Apple's budget iPhone comes with most of the iPhone 16's best features, while costing $200 ...